XTANT MEDICAL HOLDINGS, INC. (XTNT) Operating margin 2016–2025
XTANT MEDICAL HOLDINGS, INC. (XTNT) operating margin by fiscal year — reported operating income divided by reported revenue.
5.4%FY2025 · since FY2016: -8.4% → 5.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 5.4% | +15.7 pp |
| FY2024 | -10.3% | +0.8 pp |
| FY2023 | -11.1% | +0.5 pp |
| FY2022 | -11.7% | -4.7 pp |
| FY2021 | -7.0% | -5.6 pp |
| FY2020 | -1.4% | +2.1 pp |
| FY2019 | -3.5% | +79.7 pp |
| FY2018 | -83.2% | -37.4 pp |
| FY2017 | -45.8% | -37.4 pp |
| FY2016 | -8.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More XTNT financial trends
XTNT RevenueXTNT Net incomeXTNT Net marginXTNT Gross profitXTNT Gross marginXTNT Operating incomeXTNT Operating cash flowXTNT Free cash flowXTNT Capital expendituresXTNT Return on equityXTNT Stock buybacksXTNT Dividends paidXTNT Total assetsXTNT Total liabilitiesXTNT Shareholders’ equityXTNT overview →